The Patent Finder

Lunella Biotech, Inc.

Also on record
Records under this name other than the patents Lunella Biotech, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 29 patents it holds.

Showing 1 to 3 of 3 · Back to Lunella Biotech, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 11,229,657Targeting hypoxic cancer stem cells (CSCs) with doxycycline: implications for improving anti-angiogenic therapy
Lapsed on the fee record
Ended Jan 25, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 25, 2026USPTO record
US 11,197,872Vitamin C and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCs)
Lapsed on the fee record
Ended Dec 14, 2025 · USPTO record
Lapsed on the fee recordEnded Dec 14, 2025USPTO record
US 11,160,821Antimitoscins: Targeted Inhibitors of Mitochondrial Biogenesis for Eradicating Cancer Stem Cells
Lapsed on the fee record
Ended Nov 2, 2025 · High confidence
Lapsed on the fee recordEnded Nov 2, 2025High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited